BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18724824)

  • 1. Effect of Borrelia burgdorferi genotype on the sensitivity of C6 and 2-tier testing in North American patients with culture-confirmed Lyme disease.
    Wormser GP; Liveris D; Hanincová K; Brisson D; Ludin S; Stracuzzi VJ; Embers ME; Philipp MT; Levin A; Aguero-Rosenfeld M; Schwartz I
    Clin Infect Dis; 2008 Oct; 47(7):910-4. PubMed ID: 18724824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of serologic tests for lyme disease.
    Steere AC; McHugh G; Damle N; Sikand VK
    Clin Infect Dis; 2008 Jul; 47(2):188-95. PubMed ID: 18532885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved Serodiagnostic Performance for Lyme Disease by Use of Two Recombinant Proteins in Enzyme-Linked Immunosorbent Assay Compared to Standardized Two-Tier Testing.
    Bradshaw GL; Thueson RK; Uriona TJ
    J Clin Microbiol; 2017 Oct; 55(10):3046-3056. PubMed ID: 28768731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Borrelia burgdorferi sensu lato species in Europe induce diverse immune responses against C6 peptides in infected mice.
    Krupka I; Knauer J; Lorentzen L; O'Connor TP; Saucier J; Straubinger RK
    Clin Vaccine Immunol; 2009 Nov; 16(11):1546-62. PubMed ID: 19726618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Selected Borrelia burgdorferi lp54 Plasmid-Encoded Gene Products Expressed during Mammalian Infection as Antigens To Improve Serodiagnostic Testing for Early Lyme Disease.
    Weiner ZP; Crew RM; Brandt KS; Ullmann AJ; Schriefer ME; Molins CR; Gilmore RD
    Clin Vaccine Immunol; 2015 Nov; 22(11):1176-86. PubMed ID: 26376927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of different Borrelia burgdorferi sensu lato strains for detection of immune response in patients with erythema migrans.
    Merljak Skocir L; Ruzić-Sabljić E; Maraspin-Carman V; Lotric-Furlan S; Logar M; Strle F
    Int J Med Microbiol; 2008 Jul; 298(5-6):493-504. PubMed ID: 17892971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Borrelia burgdorferi spirochetes that harbor only a portion of the lp28-1 plasmid elicit antibody responses detectable with the C6 test for Lyme disease.
    Embers ME; Wormser GP; Schwartz I; Martin DS; Philipp MT
    Clin Vaccine Immunol; 2007 Jan; 14(1):90-3. PubMed ID: 17108288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Borrelia burgdorferi genotypes in patients with Lyme arthritis: High frequency of ribosomal RNA intergenic spacer type 1 strains in antibiotic-refractory arthritis.
    Jones KL; McHugh GA; Glickstein LJ; Steere AC
    Arthritis Rheum; 2009 Jul; 60(7):2174-82. PubMed ID: 19565522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of clinical variables on Borrelia burgdorferi-specific antibody seropositivity in acute-phase sera from patients in North America with culture-confirmed early Lyme disease.
    Wormser GP; Nowakowski J; Nadelman RB; Visintainer P; Levin A; Aguero-Rosenfeld ME
    Clin Vaccine Immunol; 2008 Oct; 15(10):1519-22. PubMed ID: 18716009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a sequential enzyme immunoassay testing algorithm for Lyme disease demonstrates lack of test independence but high diagnostic specificity.
    Wormser GP; Molins CR; Levin A; Lipsett SC; Nigrovic LE; Schriefer ME; Branda JA
    Diagn Microbiol Infect Dis; 2018 Jul; 91(3):217-219. PubMed ID: 29550060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant OspC from Borrelia burgdorferi sensu stricto, B. afzelii and B. garinii in the serodiagnosis of Lyme borreliosis.
    Panelius J; Lahdenne P; Heikkilä T; Peltomaa M; Oksi J; Seppälä I
    J Med Microbiol; 2002 Sep; 51(9):731-739. PubMed ID: 12358063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Accuracy of Diagnostic Tests for Lyme Disease in Humans, A Systematic Review and Meta-Analysis of North American Research.
    Waddell LA; Greig J; Mascarenhas M; Harding S; Lindsay R; Ogden N
    PLoS One; 2016; 11(12):e0168613. PubMed ID: 28002488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Borrelia burgdorferi genotype predicts the capacity for hematogenous dissemination during early Lyme disease.
    Wormser GP; Brisson D; Liveris D; Hanincová K; Sandigursky S; Nowakowski J; Nadelman RB; Ludin S; Schwartz I
    J Infect Dis; 2008 Nov; 198(9):1358-64. PubMed ID: 18781866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme-linked immunosorbent assay using recombinant OspC and the internal 14-kDa flagellin fragment for serodiagnosis of early Lyme disease.
    Rauer S; Spohn N; Rasiah C; Neubert U; Vogt A
    J Clin Microbiol; 1998 Apr; 36(4):857-61. PubMed ID: 9542898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Borrelia miyamotoi infection leads to cross-reactive antibodies to the C6 peptide in mice and men.
    Koetsveld J; Platonov AE; Kuleshov K; Wagemakers A; Hoornstra D; Ang W; Szekeres S; van Duijvendijk GLA; Fikrig E; Embers ME; Sprong H; Hovius JW
    Clin Microbiol Infect; 2020 Apr; 26(4):513.e1-513.e6. PubMed ID: 31404672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of serodiagnostics designed for use in the United States for detection of Lyme borreliosis acquired in Europe and vice versa.
    Wormser GP; Tang AT; Schimmoeller NR; Bittker S; Cooper D; Visintainer P; Aguero-Rosenfeld ME; Ogrinc K; Strle F; Stanek G
    Med Microbiol Immunol; 2014 Feb; 203(1):65-71. PubMed ID: 24218117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C6 Peptide-Based Multiplex Phosphorescence Analysis (PHOSPHAN) for Serologic Confirmation of Lyme Borreliosis.
    Pomelova VG; Korenberg EI; Kuznetsova TI; Bychenkova TA; Bekman NI; Osin NS
    PLoS One; 2015; 10(7):e0130048. PubMed ID: 26147441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible effect of mutations on serological detection of Borrelia burgdorferi sensu stricto ospC major groups: An in-silico study.
    Mechai S; Coatsworth H; Ogden NH
    PLoS One; 2023; 18(10):e0292741. PubMed ID: 37815990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to OspC, OspF and C6 antigens as indicators for infection with Borrelia burgdorferi in horses.
    Wagner B; Goodman LB; Rollins A; Freer HS
    Equine Vet J; 2013 Sep; 45(5):533-7. PubMed ID: 23432019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic parameters of modified two-tier testing in European patients with early Lyme disease.
    Baarsma ME; Schellekens J; Meijer BC; Brandenburg AH; Souilljee T; Hofhuis A; Hovius JW; van Dam AP
    Eur J Clin Microbiol Infect Dis; 2020 Nov; 39(11):2143-2152. PubMed ID: 32632699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.